Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma

Saved in:
Bibliographic Details
Main Authors: Poorvi Subramanian, Sreenidhi Mohanvelu, Dinesh Babu Somasundaram, Sheeja Aravindan, Natarajan Aravindan
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Cancer Communications
Online Access:https://doi.org/10.1002/cac2.12620
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846110413871120384
author Poorvi Subramanian
Sreenidhi Mohanvelu
Dinesh Babu Somasundaram
Sheeja Aravindan
Natarajan Aravindan
author_facet Poorvi Subramanian
Sreenidhi Mohanvelu
Dinesh Babu Somasundaram
Sheeja Aravindan
Natarajan Aravindan
author_sort Poorvi Subramanian
collection DOAJ
format Article
id doaj-art-a84713c4f3034f28b485601868144e3d
institution Kabale University
issn 2523-3548
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series Cancer Communications
spelling doaj-art-a84713c4f3034f28b485601868144e3d2024-12-24T07:55:49ZengWileyCancer Communications2523-35482024-12-0144121427143010.1002/cac2.12620Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastomaPoorvi Subramanian0Sreenidhi Mohanvelu1Dinesh Babu Somasundaram2Sheeja Aravindan3Natarajan Aravindan4Department of Physiological Sciences Oklahoma State University Stillwater Oklahoma USADepartment of Physiological Sciences Oklahoma State University Stillwater Oklahoma USAStephenson Cancer Center Oklahoma City Oklahoma USAStephenson Cancer Center Oklahoma City Oklahoma USADepartment of Physiological Sciences Oklahoma State University Stillwater Oklahoma USAhttps://doi.org/10.1002/cac2.12620
spellingShingle Poorvi Subramanian
Sreenidhi Mohanvelu
Dinesh Babu Somasundaram
Sheeja Aravindan
Natarajan Aravindan
Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma
Cancer Communications
title Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma
title_full Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma
title_fullStr Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma
title_full_unstemmed Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma
title_short Acquired RD3 loss regulates immune surveillance in high‐risk and therapy defying progressive neuroblastoma
title_sort acquired rd3 loss regulates immune surveillance in high risk and therapy defying progressive neuroblastoma
url https://doi.org/10.1002/cac2.12620
work_keys_str_mv AT poorvisubramanian acquiredrd3lossregulatesimmunesurveillanceinhighriskandtherapydefyingprogressiveneuroblastoma
AT sreenidhimohanvelu acquiredrd3lossregulatesimmunesurveillanceinhighriskandtherapydefyingprogressiveneuroblastoma
AT dineshbabusomasundaram acquiredrd3lossregulatesimmunesurveillanceinhighriskandtherapydefyingprogressiveneuroblastoma
AT sheejaaravindan acquiredrd3lossregulatesimmunesurveillanceinhighriskandtherapydefyingprogressiveneuroblastoma
AT natarajanaravindan acquiredrd3lossregulatesimmunesurveillanceinhighriskandtherapydefyingprogressiveneuroblastoma